These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25500109)

  • 21. Changes in plasma copeptin, the c-terminal portion of arginine vasopressin during water deprivation and excess in healthy subjects.
    Szinnai G; Morgenthaler NG; Berneis K; Struck J; Müller B; Keller U; Christ-Crain M
    J Clin Endocrinol Metab; 2007 Oct; 92(10):3973-8. PubMed ID: 17635944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma copeptin and chronic kidney disease risk in 3 European cohorts from the general population.
    El Boustany R; Tasevska I; Meijer E; Kieneker LM; Enhörning S; Lefèvre G; Mohammedi K; Marre M; Fumeron F; Balkau B; Bouby N; Bankir L; Bakker SJ; Roussel R; Melander O; Gansevoort RT; Velho G
    JCI Insight; 2018 Jul; 3(13):. PubMed ID: 29997293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in Plasma Copeptin Levels during Hemodialysis: Are the Physiological Stimuli Active in Hemodialysis Patients?
    Ettema EM; Kuipers J; Assa S; Bakker SJ; Groen H; Westerhuis R; Gaillard CA; Gansevoort RT; Franssen CF
    PLoS One; 2015; 10(5):e0127116. PubMed ID: 25973954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Copeptin, a surrogate marker of vasopressin, is associated with accelerated renal function decline in renal transplant recipients.
    Meijer E; Bakker SJ; de Jong PE; Homan van der Heide JJ; van Son WJ; Struck J; Lems SP; Gansevoort RT
    Transplantation; 2009 Aug; 88(4):561-7. PubMed ID: 19696640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin.
    Morgenthaler NG; Struck J; Alonso C; Bergmann A
    Clin Chem; 2006 Jan; 52(1):112-9. PubMed ID: 16269513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma copeptin, a possible prognostic marker in cirrhosis.
    Moreno JP; Grandclement E; Monnet E; Clerc B; Agin A; Cervoni JP; Richou C; Vanlemmens C; Dritsas S; Dumoulin G; Di Martino V; Thevenot T
    Liver Int; 2013 Jul; 33(6):843-51. PubMed ID: 23560938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic Value of Copeptin in Chronic Kidney Disease: From General Population to End-Stage Renal Disease.
    Golembiewska E; Machowska A; Stenvinkel P; Lindholm B
    Curr Protein Pept Sci; 2017; 18(12):1232-1243. PubMed ID: 28714397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kidney function and plasma copeptin levels in healthy kidney donors and autosomal dominant polycystic kidney disease patients.
    Zittema D; van den Berg E; Meijer E; Boertien WE; Muller Kobold AC; Franssen CF; de Jong PE; Bakker SJ; Navis G; Gansevoort RT
    Clin J Am Soc Nephrol; 2014 Sep; 9(9):1553-62. PubMed ID: 24993447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Copeptin Plasma Levels are Associated with Decline of Renal Function in Patients with Type 2 Diabetes Mellitus.
    Villela-Torres ML; Higareda-Mendoza AE; Gómez-García A; Alvarez-Paredes AR; García-López E; Stenvikel P; Gu HF; Rashid-Qureshi A; Lindholm B; Alvarez-Aguilar C
    Arch Med Res; 2018 Jan; 49(1):36-43. PubMed ID: 29665969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma copeptin as a predictor of kidney disease.
    Enhörning S; Christensson A; Melander O
    Nephrol Dial Transplant; 2019 Jan; 34(1):74-82. PubMed ID: 29471407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High copeptin concentrations in umbilical cord blood after vaginal delivery and birth acidosis.
    Wellmann S; Benzing J; Cippà G; Admaty D; Creutzfeldt R; Mieth RA; Beinder E; Lapaire O; Morgenthaler NG; Haagen U; Szinnai G; Bührer C; Bucher HU
    J Clin Endocrinol Metab; 2010 Nov; 95(11):5091-6. PubMed ID: 20702521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
    J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma copeptin levels and prediction of outcome in heart failure outpatients: relation to hyponatremia and loop diuretic doses.
    Balling L; Kistorp C; Schou M; Egstrup M; Gustafsson I; Goetze JP; Hildebrandt P; Gustafsson F
    J Card Fail; 2012 May; 18(5):351-8. PubMed ID: 22555263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postoperative Copeptin Concentration Predicts Diabetes Insipidus After Pituitary Surgery.
    Winzeler B; Zweifel C; Nigro N; Arici B; Bally M; Schuetz P; Blum CA; Kelly C; Berkmann S; Huber A; Gentili F; Zadeh G; Landolt H; Mariani L; Müller B; Christ-Crain M
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2275-82. PubMed ID: 25923040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urine Potassium Excretion, Kidney Failure, and Mortality in CKD.
    Leonberg-Yoo AK; Tighiouart H; Levey AS; Beck GJ; Sarnak MJ
    Am J Kidney Dis; 2017 Mar; 69(3):341-349. PubMed ID: 27233381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Copeptin in heart transplant recipients depends on kidney function and intraventricular septal thickness.
    Przybylowski P; Malyszko J; Malyszko JS
    Transplant Proc; 2010 Jun; 42(5):1808-11. PubMed ID: 20620528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Twenty-four hour urinary urea excretion and 9-year risk of hypertension: the PREVEND study.
    Tielemans SM; Geleijnse JM; van Baak MA; Engberink MF; Brink EJ; de Jong PE; Gansevoort RT; Bakker SJ;
    J Hypertens; 2013 Aug; 31(8):1564-9. PubMed ID: 23751964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Copeptin and its relation to arteriovenous fistula (AVF) type and NYHA class in hemodialysis patients.
    Malyszko J; Levin-Iaina N; Malyszko JS; Kozminski P; Koc-Zorawska E; Mysliwiec M
    Ren Fail; 2011; 33(10):929-34. PubMed ID: 22013928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apelin and copeptin: two opposite biomarkers associated with kidney function decline and cyst growth in autosomal dominant polycystic kidney disease.
    Lacquaniti A; Chirico V; Lupica R; Buemi A; Loddo S; Caccamo C; Salis P; Bertani T; Buemi M
    Peptides; 2013 Nov; 49():1-8. PubMed ID: 23973863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Copeptin Associates with Cause-Specific Mortality in Patients with Impaired Renal Function: Results from the LURIC and the 4D Study.
    Krane V; Genser B; Kleber ME; Drechsler C; März W; Delgado G; Allolio B; Wanner C; Fenske W;
    Clin Chem; 2017 May; 63(5):997-1007. PubMed ID: 28280053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.